eagle-i University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

The use of American ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind, placebo-controlled phase III study

eagle-i ID


Resource Type

  1. Clinical trial


  1. ClinicalTrials.gov url
  2. Intervention
    American ginseng
  3. Resource Description
    This randomized phase III trial is studying American ginseng to see how well it works in treating patients with fatigue caused by cancer.
  4. Contact
    Berenberg, Jeffrey
  5. PI
    Berenberg, Jeffrey
  6. Topic
  7. Study Population
    Candidates are at least 18 years old and have been diagnosed with cancer within 2 years. The candidate must have finished at least one course of chemotherapy or targeted therapy or at least 1 week of radiation therapy and must have experienced fatigue for at least 1 month. There must be no brain metastasis or primary CNS cancer, there must have been no previous use of ginseng capsules.
  8. Funded by
    North Central Cancer Treatment Group
  9. Phase
    Phase 3 clinical trial
  10. Performed by
    Clinical Protocol & Data Management Shared Resource
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016